Pub. Date : 2014 Feb
PMID : 24266843
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Many c-MET inhibitors are now under clinical investment, and one of them - Cabozantinib - has been approved by US FDA in 2012 for the treatment of medullary thyroid cancer, which further proved the feasibility of c-MET inhibition method in cancer therapy. | cabozantinib | MET proto-oncogene, receptor tyrosine kinase | Homo sapiens |
| 2 | Many c-MET inhibitors are now under clinical investment, and one of them - Cabozantinib - has been approved by US FDA in 2012 for the treatment of medullary thyroid cancer, which further proved the feasibility of c-MET inhibition method in cancer therapy. | cabozantinib | MET proto-oncogene, receptor tyrosine kinase | Homo sapiens |